GlaxoSmithKline v. Classen Immunotherapies, Inc.
567 U.S. 932, 133 S. Ct. 50, 183 L. Ed. 2d 672, 80 U.S.L.W. 3707, 2012 U.S. LEXIS 4709
Opinion
C. A. Fed. Cir. The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Free access — add to your briefcase to read the full text and ask questions with AI
GlaxoSmithKline v. Classen Immunotherapies, Inc., 567 U.S. 932, 133 S. Ct. 50, 183 L. Ed. 2d 672, 80 U.S.L.W. 3707, 2012 U.S. LEXIS 4709 (2012).
567 U.S. 932 (GlaxoSmithKline v. Classen Immunotherapies, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.